These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 29776627)

  • 1. Introduction: Molecular Medicine in the Common Era: Applications and Impact of Molecular Pathology in Health and Disease.
    Bluth MH
    Clin Lab Med; 2018 Jun; 38(2):209-213. PubMed ID: 29776627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Introduction: the impact of molecular pathology on the practice of pathology.
    Bluth MH
    Clin Lab Med; 2013 Dec; 33(4):749-51. PubMed ID: 24267183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic pathology and laboratory medicine in the age of "omics": a paper from the 2006 William Beaumont Hospital Symposium on Molecular Pathology.
    Finn WG
    J Mol Diagn; 2007 Sep; 9(4):431-6. PubMed ID: 17652635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Advances of Molecular Diagnostic Techniques Application in Clinical Diagnosis.].
    Ying BW
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Nov; 47(6):908-915. PubMed ID: 28598123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular tumor diagnostics-current methods, examples of application and future].
    Sobottka B; Weber A
    Pathologe; 2020 Jul; 41(4):411-424. PubMed ID: 32430586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next-generation sequencing applied to rare diseases genomics.
    Danielsson K; Mun LJ; Lordemann A; Mao J; Lin CH
    Expert Rev Mol Diagn; 2014 May; 14(4):469-87. PubMed ID: 24702023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How novel molecular diagnostic technologies and biomarkers are revolutionizing genetic testing and patient care.
    Baudhuin LM; Donato LJ; Uphoff TS
    Expert Rev Mol Diagn; 2012 Jan; 12(1):25-37. PubMed ID: 22133117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next-Generation Sequencing for Infectious Disease Diagnosis and Management: A Report of the Association for Molecular Pathology.
    Lefterova MI; Suarez CJ; Banaei N; Pinsky BA
    J Mol Diagn; 2015 Nov; 17(6):623-34. PubMed ID: 26433313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Next-Generation Sequencing Informatics: Challenges and Strategies for Implementation in a Clinical Environment.
    Roy S; LaFramboise WA; Nikiforov YE; Nikiforova MN; Routbort MJ; Pfeifer J; Nagarajan R; Carter AB; Pantanowitz L
    Arch Pathol Lab Med; 2016 Sep; 140(9):958-75. PubMed ID: 26901284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An interview with Manuel Salto-Tellez on diagnostic pathology: the future is morphomolecular.
    Salto-Tellez M; Raison C
    Expert Rev Mol Diagn; 2015 May; 15(5):585-8. PubMed ID: 25838030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Pathology: Prognostic and Diagnostic Genomic Markers for Myeloid Neoplasms.
    Kuo FC
    Surg Pathol Clin; 2016 Sep; 9(3):475-88. PubMed ID: 27523973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists.
    Li MM; Datto M; Duncavage EJ; Kulkarni S; Lindeman NI; Roy S; Tsimberidou AM; Vnencak-Jones CL; Wolff DJ; Younes A; Nikiforova MN
    J Mol Diagn; 2017 Jan; 19(1):4-23. PubMed ID: 27993330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular pathology techniques.
    Bluth MJ; Bluth MH
    Clin Lab Med; 2013 Dec; 33(4):753-72. PubMed ID: 24267184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personalized medicine and development of targeted therapies: The upcoming challenge for diagnostic molecular pathology. A review.
    Dietel M; Sers C
    Virchows Arch; 2006 Jun; 448(6):744-55. PubMed ID: 16736190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene and Variant Annotation for Mendelian Disorders in the Era of Advanced Sequencing Technologies.
    Chakravorty S; Hegde M
    Annu Rev Genomics Hum Genet; 2017 Aug; 18():229-256. PubMed ID: 28415856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PathOS: a decision support system for reporting high throughput sequencing of cancers in clinical diagnostic laboratories.
    Doig KD; Fellowes A; Bell AH; Seleznev A; Ma D; Ellul J; Li J; Doyle MA; Thompson ER; Kumar A; Lara L; Vedururu R; Reid G; Conway T; Papenfuss AT; Fox SB
    Genome Med; 2017 Apr; 9(1):38. PubMed ID: 28438193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular diagnostics-an emerging frontier in dermatopathology.
    Dadzie OE; Neat M; Emley A; Bhawan J; Mahalingam M
    Am J Dermatopathol; 2011 Feb; 33(1):1-13; quiz 14-6. PubMed ID: 20664321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Label-free screening of single biomolecules through resistive pulse sensing technology for precision medicine applications.
    Harrer S; Kim SC; Schieber C; Kannam S; Gunn N; Moore S; Scott D; Bathgate R; Skafidas S; Wagner JM
    Nanotechnology; 2015 May; 26(18):182502. PubMed ID: 25875197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-throughput «Omics» technologies: New tools for the study of triple-negative breast cancer.
    Judes G; Rifaï K; Daures M; Dubois L; Bignon YJ; Penault-Llorca F; Bernard-Gallon D
    Cancer Lett; 2016 Nov; 382(1):77-85. PubMed ID: 26965997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of advanced molecular technology in the diagnosis and management of genetic disorders in South Africa.
    Kotze M
    S Afr Med J; 2016 May; 106(6 Suppl 1):S114-8. PubMed ID: 27245544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.